Literature DB >> 9492986

Activation of autoreactive T cells by peptides from human pathogens.

S Hausmann1, K W Wucherpfennig.   

Abstract

Activation of autoreactive T cells is a necessary-but not sufficient-step in the development of T cell mediated autoimmunity. Autoreactive T cells can be activated by viral and bacterial peptides that meet the structural requirements for MHC molecule binding and T cell receptor recognition. Due to the degenerate nature of MHC class II molecule binding motifs and a certain degree of flexibility in T cell receptor recognition, such microbial peptides have been found to be quite distinct in their primary sequence from the self-peptide they mimic.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9492986      PMCID: PMC7134830          DOI: 10.1016/s0952-7915(97)80186-0

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  56 in total

1.  Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.

Authors:  K W Wucherpfennig; I Catz; S Hausmann; J L Strominger; L Steinman; K G Warren
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Peptide recognition, T cell receptor usage and HLA restriction elements of human heat-shock protein (hsp) 60 and mycobacterial 65-kDa hsp-reactive T cell clones from rheumatoid synovial fluid.

Authors:  A J Quayle; K B Wilson; S G Li; J Kjeldsen-Kragh; F Oftung; T Shinnick; M Sioud; O Førre; J D Capra; J B Natvig
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

3.  Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.

Authors:  M Vergelli; B Hemmer; M Kalbus; A B Vogt; N Ling; P Conlon; J E Coligan; H McFarland; R Martin
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

4.  Differential contact of disparate class I/peptide complexes as the basis for epitope cross-recognition by a single T cell receptor.

Authors:  D J Loftus; Y Chen; D G Covell; V H Engelhard; E Appella
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

5.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.

Authors:  D N Garboczi; P Ghosh; U Utz; Q R Fan; W E Biddison; D C Wiley
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

6.  A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity.

Authors:  M D Tallquist; T J Yun; L R Pease
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

7.  Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features.

Authors:  K G Warren; I Catz; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands.

Authors:  B D Evavold; J Sloan-Lancaster; K J Wilson; J B Rothbard; P M Allen
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

9.  Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.

Authors:  K W Wucherpfennig; D A Hafler; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

10.  HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases.

Authors:  S Shimoda; M Nakamura; H Ishibashi; K Hayashida; Y Niho
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  8 in total

1.  Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells.

Authors:  H Wedemeyer; E Mizukoshi; A R Davis; J R Bennink; B Rehermann
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 2.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 3.  Toll-like receptors in multiple sclerosis.

Authors:  Michael K Racke; Paul D Drew
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 4.  Autoimmunity. Thoughts for the millennium.

Authors:  I R Mackay; J Van de Water; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2000-02       Impact factor: 10.817

5.  Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers.

Authors:  Kresimir Dolic; Bianca Weinstock-Guttman; Karen Marr; Vesela Valnarov; Ellen Carl; Jesper Hagemeier; Christina Brooks; Colleen Kilanowski; David Hojnacki; Murali Ramanathan; Robert Zivadinov
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

Review 6.  The cancer stem cell: evidence for its origin as an injured autoreactive T cell.

Authors:  Peter Grandics
Journal:  Mol Cancer       Date:  2006-02-14       Impact factor: 27.401

7.  On the role of the innate immunity in autoimmune disease.

Authors:  M F Bachmann; M Kopf
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

Review 8.  Private aspects of heterologous immunity.

Authors:  Barbara Rehermann; Eui-Cheol Shin
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.